Supernus to Participate in Upcoming September Investor Conferences
Citi’s 16th Annual
Date: Thursday, September 9, 2021
Participation Type: One-on-one meetings
Wells Fargo 2021
Participation Type: Presentation
Presentation Time: 9:20 a.m. ET
Morgan Stanley 19th Annual Global Healthcare Conference
Date: Wednesday, September 15, 2021
Participation Type: Fireside Chat
Presentation Time: 11:45 a.m. ET
A live webcast of the events can be accessed by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay of each webcast will be available for 60 days on the Company's website after the respective conference.
Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease, cervical dystonia and chronic sialorrhea. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in Parkinson’s disease, epilepsy, depression and rare CNS disorders.
For more information, please visit www.supernus.com.
Tel: (301) 838-2591
Office: (443) 213-0505
Mobile: (443) 377-4767
Source: Supernus Pharmaceuticals, Inc.